Cargando…

Lactate Dehydrogenase B Is Associated with the Response to Neoadjuvant Chemotherapy in Oral Squamous Cell Carcinoma

Oral squamous cell carcinoma (OSCC) comprises a subset of head and neck squamous cell carcinoma (HNSCC) with poor therapeutic outcomes and high glycolytic dependency. Neoadjuvant chemotherapy regimens of docetaxel, cisplatin and 5-fluorouracil (TPF) are currently accepted as standard regimens for HN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Wenyi, Zhang, Xiaomin, Ding, Xu, Li, Huaiqi, Geng, Meiyu, Xie, Zuoquan, Wu, Heming, Huang, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431727/ https://www.ncbi.nlm.nih.gov/pubmed/25973606 http://dx.doi.org/10.1371/journal.pone.0125976

Ejemplares similares

Phosphoglycerate Mutase 1 Predicts the Poor Prognosis of Oral Squamous Cell Carcinoma and is Associated with Cell Migration
por: Zhang, Dadong, et al.
Publicado: (2017)

Phosphoglycerate Mutase 1 Predicts the Poor Prognosis of Oral Squamous Cell Carcinoma and is Associated with Cell Migration - Erratum
por: Zhang, Dadong, et al.
Publicado: (2020)

Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation
por: Du, Mengyan, et al.
Publicado: (2022)

Histopathological differentiation of oral squamous cell carcinoma and salivary lactate dehydrogenase: A biochemical study
por: D’Cruz, Audrey M., et al.
Publicado: (2015)

Serum and salivary levels of lactate dehydrogenase in oral squamous cell carcinoma, oral lichen planus and oral lichenoid reaction
por: Gholizadeh, Narges, et al.
Publicado: (2020)

Increased lactate dehydrogenase activity is dispensable in squamous carcinoma cells of origin
por: Flores, A., et al.
Publicado: (2019)

Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma
por: Huang, Luo, et al.
Publicado: (2020)

Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer
por: Li, Jing, et al.
Publicado: (2016)

Author Correction: Increased lactate dehydrogenase activity is dispensable in squamous carcinoma cells of origin
por: Flores, A., et al.
Publicado: (2019)

A study of salivary lactate dehydrogenase isoenzyme levels in patients with oral leukoplakia and squamous cell carcinoma by gel electrophoresis method
por: Joshi, Priya Shirish, et al.
Publicado: (2014)

Utility of serum and salivary lactate dehydrogenase and uric acid levels as a diagnostic profile in oral squamous cell carcinoma patients
por: Anitha, G, et al.
Publicado: (2022)

Neoadjuvant PD‐1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung
por: Feng, Yuan, et al.
Publicado: (2021)

The oncological outcome and influence of neoadjuvant chemotherapy on the surgery in the resectable and locally advanced oral squamous cell carcinoma
por: Su, Xuan, et al.
Publicado: (2019)

Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis
por: Kong, Weihao, et al.
Publicado: (2018)

Prognostic Significance of Lactate Dehydrogenase in Patients Undergoing Surgical Resection for Laryngeal Squamous Cell Carcinoma
por: Guo, Erliang, et al.
Publicado: (2020)

Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
por: Li, Yan, et al.
Publicado: (2022)

Acetylation at lysine 71 inactivates superoxide dismutase 1 and sensitizes cancer cells to genotoxic agents
por: Lin, Chenchu, et al.
Publicado: (2015)

Long Noncoding RNA LINC00460 Promotes Cell Progression by Sponging miR-4443 in Head and Neck Squamous Cell Carcinoma
por: Li, Meng, et al.
Publicado: (2020)

H-2-controlled suppression of T cell response to lactate dehydrogenase B. Characterization of the lactate dehydrogenase B suppressor pathway
Publicado: (1982)

The Role of Adjuvant Chemotherapy in the Treatment of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemotherapy
por: Li, Keting, et al.
Publicado: (2023)

Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma
por: Chen, Yongshun, et al.
Publicado: (2018)

Outcome of Neoadjuvant Chemotherapy on Local Recurrence and Distant Metastasis of Oral Squamous Cell Carcinoma: A Retrospective Study
por: Tabrizi, Reza, et al.
Publicado: (2016)

Prognostic value of lactate dehydrogenase to albumin ratio (LAR) in patients with resectable esophageal squamous cell carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2019)

Efficacy and safety of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral squamous cell carcinoma (OSCC)
por: Kashyap1, Lakhan, et al.
Publicado: (2021)

Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma
por: Chen, Yongshun, et al.
Publicado: (2022)

Estimation of Salivary and Serum Lactate Dehydrogenase in Oral Submucous Fibrosis
por: Mishra, Silpiranjan, et al.
Publicado: (2018)

Chronic Kidney Disease and Cognitive Impairment: The Kidney-Brain Axis
por: Xie, Zuoquan, et al.
Publicado: (2022)

Prognostic significance of p53 immunoexpression in the survival of oral squamous cell carcinoma patients treated with surgery and neoadjuvant chemotherapy
por: LI, LI, et al.
Publicado: (2013)

Clinical Response to Neoadjuvant Immunotherapy Combined with Targeted Therapy and Chemotherapy in Oral Squamous Cell Carcinoma: Experience in Three Patients
por: Tian, Yu, et al.
Publicado: (2022)

Neoadjuvant chemotherapy for invasive squamous cell carcinoma of the conjunctiva: A case report
por: Nair, Akshay Gopinathan, et al.
Publicado: (2015)

Cloning and Polymorphisms of Yak Lactate Dehydrogenase b Gene
por: Wang, Guosheng, et al.
Publicado: (2013)

A phase II, single-centre trial of neoadjuvant toripalimab plus chemotherapy in locally advanced esophageal squamous cell carcinoma
por: Xing, Wenqun, et al.
Publicado: (2020)

Dihydropyrimidine dehydrogenase mutation in neoadjuvant chemotherapy in head and neck cancers: Myth or reality?
por: Patil, Vijay M., et al.
Publicado: (2016)

Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real−world retrospective study
por: Wu, Wen-Jie, et al.
Publicado: (2023)

Lactate Conversion by Lactate Dehydrogenase B Is Involved in Beige Adipocyte Differentiation and Thermogenesis in Mice
por: Guo, Bin, et al.
Publicado: (2023)

Clinical relevance of serum lipids in the carcinogenesis of oral squamous cell carcinoma
por: Qian, Ling, et al.
Publicado: (2023)

Monocarboxylate Transporter 4 Facilitates Cell Proliferation and Migration and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma Patients
por: Zhu, Jiang, et al.
Publicado: (2014)

Effect of Body Composition Change during Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma
por: Onishi, Sachiyo, et al.
Publicado: (2022)

Neoadjuvant Sintilimab Plus Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
por: Lv, Huilai, et al.
Publicado: (2022)

Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New
por: Faloppi, Luca, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hvciv9fcsj388k1k4u8el89s4l